Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aurora kinase B (Aurora B) is a vital serine/threonine kinase that acts as the catalytic core of the Chromosomal Passenger Complex (CPC). Its function is intrinsically linked to the Inner Centromere Protein (INCENP), which serves as a scaffold and an essential allosteric activator; binding of the INCENP IN-box to Aurora B induces the active conformation of the kinase's T-loop [1, 2]. This complex is a master regulator of mitosis, ensuring accurate chromosome condensation, proper kinetochore-microtubule attachments, and the successful completion of cytokinesis [7, 12]. In many cancers, the Aurora B-INCENP complex is overexpressed, contributing to chromosomal instability, aneuploidy, and aggressive tumor progression [9, 10, 13]. As a result, it is a high-priority therapeutic target, with several small-molecule inhibitors designed to compete for the ATP-binding site of Aurora B, thereby inducing mitotic catastrophe and apoptosis in rapidly dividing cells [3, 10]. However, the clinical development of these inhibitors has been hampered by significant safety concerns, particularly dose-limiting neutropenia and the potential for off-target effects on normal cell division [10].
ATP-competitive inhibition of the Aurora kinase B catalytic subunit within the Aurora B-INCENP complex, which prevents the phosphorylation of key mitotic substrates such as Histone H3 and MCAK, thereby disrupting chromosome alignment, spindle assembly checkpoint signaling, and cytokinesis [2, 10].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aurora kinase B-Inner centromere protein complex (Aurora B-INCENP).